Abstract |
The factors conferring the increased malignancy on lung adenocarcinoma with micropapillary component (AC-MPC) remain to be elucidated. On proteomics based on 2-dimensional gel electrophoresis, 19 proteins differentially expressed by more than 1.5-fold between AC-MPC and conventional adenocarcinoma (CAC); in particular, vimentin, one of the proteins, was 3.5-fold up-regulated in AC-MPC. Subsequent semi-quantitative investigation by immunohistochemistry with large cohorts comprised 101 AC-MPC and 119 CAC, respectively, of different stages revealed that vimentin was expressed in MPC of 95 (94.1%) AC-MPC and the expression scores were higher than those of well- and moderately differentiated CAC, as well as the background non-MPC of the AC-MPC (P < 0.0001), but not significantly different from those of poorly differentiated CAC (P = 0.561). Even within the AC-MPC entity, higher vimentin expression was correlated with more frequent vascular invasion and more advanced node metastasis (P < 0.02), and multivariate analysis showed that high vimentin expression and worse node statuses were independent indicators of adverse prognosis (P < 0.048). In conclusion, vimentin expression is prevalent and markedly up-regulated in MPC, which might reflect the biological essence of poorer differentiation or dedifferentiation of MPC, and this might have a role in the acquisition and increase of invasiveness and consequent more malignant nature of MPC.
|
Authors | Hiroyasu Nakashima, Shi-Xu Jiang, Yuichi Sato, Keika Hoshi, Toshihide Matsumoto, Ryo Nagashio, Makoto Kobayashi, Yukiko Matsuo, Kazu Shiomi, Kazushige Hayakawa, Makoto Saegusa, Yukitoshi Satoh |
Journal | Pathology international
(Pathol Int)
Vol. 65
Issue 4
Pg. 183-92
(Apr 2015)
ISSN: 1440-1827 [Electronic] Australia |
PMID | 25684590
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd. |
Chemical References |
- Biomarkers, Tumor
- Vimentin
|
Topics |
- Adenocarcinoma
(metabolism, mortality, pathology)
- Adenocarcinoma of Lung
- Aged
- Biomarkers, Tumor
(analysis)
- Carcinoma, Papillary
(metabolism, mortality, pathology)
- Disease-Free Survival
- Electrophoresis, Gel, Two-Dimensional
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lung Neoplasms
(metabolism, mortality, pathology)
- Male
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Up-Regulation
- Vimentin
(analysis, biosynthesis)
|